Tuesday, February 7, 2017

Evolut R Improved on Some Earlier Gen Outcomes (CME/CE)

(MedPage Today) -- But paravalvular regurgitation and pacemaker rates are still a problem
via Evolut R Improved on Some Earlier Gen Outcomes (CME/CE)
by

No comments:

Post a Comment